Nabil Adam is a Professor Emeritus at Rutgers University and Co-founder and CEO of Phalcon, LLC. Dr. Adam is leveraging AI, specifically Deep Learning, to revolutionize Opioid Use Disorder (OUD) treatment. By identifying and validating FDA-approved drugs for repurposing, their approach could lead to more effective treatments, improving outcomes like reduced mortality, better treatment retention, and fewer emergency visits. This innovative work aims to provide evidence-supported treatment recommendations and pave the way for new clinical trials, offering hope to millions affected by OUD.